Biogen Inc Stock Alpha and Beta Analysis
| BIIB Stock | USD 190.52 1.64 0.85% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biogen Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biogen over a specified time horizon. Remember, high Biogen's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biogen's market risk premium analysis include:
Beta 1.35 | Alpha (0.46) | Risk 1.59 | Sharpe Ratio (0.26) | Expected Return (0.41) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biogen |
Biogen Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biogen market risk premium is the additional return an investor will receive from holding Biogen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biogen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biogen's performance over market.| α | -0.46 | β | 1.35 |
Biogen expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Biogen's Buy-and-hold return. Our buy-and-hold chart shows how Biogen performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Biogen Market Price Analysis
Market price analysis indicators help investors to evaluate how Biogen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biogen shares will generate the highest return on investment. By understating and applying Biogen stock market price indicators, traders can identify Biogen position entry and exit signals to maximize returns.
Biogen Return and Market Media
The median price of Biogen for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 is 221.02 with a coefficient of variation of 7.37. The daily time series for the period is distributed with a sample standard deviation of 16.52, arithmetic mean of 224.26, and mean deviation of 13.39. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 634 shares by Ginger Gregory of Biogen at 240.98 subject to Rule 16b-3 | 03/08/2024 |
2 | BioArctic Professor Lars Lannfelt, awarded Fondation Recherche Alzheimers European Grand Prix for his contributions to science and treatment of Alzheimers disea... | 03/19/2024 |
3 | Biogen Inc. Dips More Than Broader Market What You Should Know | 03/25/2024 |
4 | Eisai submits sBLA for monthly maintenance dose of Alzheimers drug Leqembi | 04/01/2024 |
5 | Acquisition by Nicole Murphy of 240 shares of Biogen subject to Rule 16b-3 | 04/03/2024 |
6 | 158,000 ALS drug pulled from market after failing in large clinical trial | 04/05/2024 |
7 | Morning Brew Tech Giants Lead Market Movements Amid Earnings Reports | 04/09/2024 |
8 | Nurix Up on Upbeat Initial Data From Phase I Cancer Study | 04/10/2024 |
9 | INVESTOR CALLVirtualwares CEO to present Annual Report to shareholders | 04/11/2024 |
10 | Global Pulmonary Fibrosis Biomarkers Market Size To Exceed USD 6.1 Billion By 2033 CAGR of 4.3 | 04/12/2024 |
11 | Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer | 04/15/2024 |
12 | Medicare spending on Biogens Alzheimers drug to hit 3.5B | 04/16/2024 |
13 | Sage Therapeutics stock holds Market Perform amid setbacks | 04/17/2024 |
About Biogen Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biogen or other stocks. Alpha measures the amount that position in Biogen Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.00228 | 0.002166 | Price To Sales Ratio | 3.81 | 3.62 |
Biogen Upcoming Company Events
As portrayed in its financial statements, the presentation of Biogen's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biogen's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biogen's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biogen. Please utilize our Beneish M Score to check the likelihood of Biogen's management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Biogen
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Biogen Backtesting, Biogen Valuation, Biogen Correlation, Biogen Hype Analysis, Biogen Volatility, Biogen History and analyze Biogen Performance. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Biogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.